#Cing

Pre-purchase Dear me, I was... on Steam A short tale, a long journey. With a beautiful watercolor touch, it depicts the life of a woman. In her ordinary and modest life...experience her joys, her sorrows, her growth. Witness the story she s...

1 month ago

Dear Me, I was already has a Steam page and you can already purchase it, same price it had on Nintendo Switch 2, just go buy it! :D

#DearMeIWas #Gaming #Steam #Cing #ArcSys

3 0 0 0

Dear me, I was… - A look back into our life I’ve talked a lot about Cing in my Another Code Recollection blog, about how this company really stuck with me and about my hope that somed...

1 month ago

#DearMeIWas Is coming to #NintendoSwitch, #Steam, #iOS and #Android on February 12. I wrote about It last Year, It was an absolutely intense experience at a steal of a price. If you're uncertain about getting the game, click the link to learn more

SUPPORT THIS GAME 😭

#Cing #ArcSystemWorks

2 1 0 0

heinous lesbians unit

@eleyowza.bsky.social

1 month ago

mila evans, melissa woodward, rosa fox, and louis denonno from hotel dusk: room 215. melissa and mila are sitting on the stairs as rosa and louie look up at them.

a redraw of kyle hyde and brian bradley’s photograph.

happy 19th birthday to this beautiful, beautiful game that i will cherish in my heart forever. cheers 🥃

#hoteldusk #cing #clemart

13 8 1 0

Adrot

@adrot.bsky.social

2 months ago

In the "Games released today" section of the Nintendo Today apo, there is a random copyright that mentions Cing. This coincides with the release of Last Window, yet the game is not visible on the page.

N-Nintendo...? Is there someone you forgot to mention today...?
#Cing #lastwindow #hoteldusk

5 0 0 1

heinous lesbians unit

@eleyowza.bsky.social

3 months ago

chibis of sumio mondo from flower sun and rain, chizuru hachisuka from the silver case, rachel and kyle hyde from hotel dusk/last window.

squashing my hotel dusk blorbos of 8 mths together with my kill the past blorbos of 3 days almost like im acclimating everyone to the ktpposting that i am about to do, good lord

#flowersunandrain #thesilvercase #hoteldusk #cing #suda51 #killthepast

13 2 1 0

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25 Cingulate (NASDAQ: CING) updated 3Q25 progress as it advances CTx-1301 toward a potential commercial ADHD launch. Key developments include FDA acceptance of the CTx-1301 NDA with a May 31, 2026 PDUFA date, presentation of positive pediatric Phase 3 data showing rapid onset and full active‑day symptom control, and an exclusive U.S. supply agreement with Bend Bio Sciences to secure manufacturing capacity.Commercial build continues with a new Chief Commercial Officer, an Indegene partnership, quarter‑end cash of ~$6.1M, and a post‑quarter $6M financing that the company says extends runway into 2Q26.

3 months ago

#CING Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25

www.stocktitan.net/news/CING/stonegate-capi...

0 0 0 0

Zacks Small Cap Research

@zackssmallcap.bsky.social

3 months ago

#CING: Third Quarter Results buff.ly/Qep5J7q

0 0 0 0

Videospielgeschichten

@vsgde.bsky.social

3 months ago

Ashley und ihre Tante Jessica auf dem Weg, die Geheimnisse der Vergangenheit zu lüften

NEU IM BLOG: Väterlose Teenager und dubiose Forschungsprojekte – die CING-Studios machen mit Another Code Hollywood Konkurrenz.

www.videospielgeschichten.de/cing-mir-das-lied-vom-co...

#cing #visualnovel #anothercode

2 0 0 0

Videospielgeschichten

@vsgde.bsky.social

3 months ago

CING mir das Lied vom Code Väterlose Teenager und dubiose Forschungsprojekte - die CING-Studios machen mit Another Code Hollywood Konkurrenz.

Neu im Blog von Sven Hannich: CING mir das Lied vom Code

Väterlose Teenager und dubiose Forschungsprojekte – die CING-Studios machen mit Another Code Hollywood Konkurrenz.

www.videospielgeschichten.de/cing-mir-das-lied-vom-co...

#Adventure #AnotherCode #Cing #HotelDusk #Visual novel

1 0 0 1

4 months ago

#CING #CINGW Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/CING/cingulate-inc-...

0 0 0 0

Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301 Cingulate (NASDAQ: CING) appointed Bryan Downey as Chief Commercial Officer and announced FDA acceptance of its New Drug Application for CTx-1301 with a PDUFA date of May 31, 2026. The company completed a $6.0 million financing via a $6,570,000 unsecured promissory note carrying 9% interest and maturing in 18 months, which the company says extends cash runway into Q2 2026. Downey received 30,000 inducement stock options at a $3.80 exercise price, vesting over four years. Cingulate is preparing commercial infrastructure with partner Indegene, pending FDA approval.

4 months ago

#CING #CINGW Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

www.stocktitan.net/news/CING/cingulate-name...

0 0 0 0

Kyriaki Michailidou

@kmichailidou.bsky.social

4 months ago

Just a Paranormal office ! #biostatisticsUnitCING #booo #CING #stats

1 0 0 0

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of

4 months ago

#CING #CINGW Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

www.stocktitan.net/news/CING/cingulate-pres...

0 0 0 0

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting Cingulate (NASDAQ: CING) announced that Phase 3 data for its lead ADHD candidate CTx-1301 (dexmethylphenidate HCl) was selected for a podium presentation at the AACAP Annual Meeting in Chicago.Dr. Ann Childress will present “Efficacy and Safety of CTx-1301 in Pediatric Subjects With ADHD” on October 24, 2025. The session will be livestreamed and results will be summarized in a follow-up company announcement after the conference.

4 months ago

#CING #CINGW Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

www.stocktitan.net/news/CING/cingulate-s-le...

0 0 0 0

4 months ago

I found this old photo of me playing Last Window Secret of Cape West on my 3DS. The girl, Mila, asks for a portrait and you have to draw her on the touchscreen.

I gave it my best 🤣🤣

#NintendoDS #Art #HotelDusk #Cing

4 1 0 0

FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date Cingulate Inc. (NASDAQ: CING) a biopharmaceutical company

5 months ago

#CING #CINGW FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date

www.stocktitan.net/news/CING/fda-accepts-ci...

0 0 0 0

Dear me, I was… - Uno sguardo alla nostra vita Ho parlato a lungo di Cing nel mio blog su Another Code Recollection , di come quella compagnia mi fosse rimasta particolarmente impressa e ...

5 months ago

Dear Me, I was... è finora la più grande sorpresa di
#NintendoSwitch2. Una corta avventura senza dialoghi, meraviglioso artwork e una storia che vi darà molto da riflettere una volta finita. Buona lettura!

#Blog #Recensione #Writing #Videogioco #VisualNovel #Cing #ArcSystemWorks

2 1 1 0

Dear me, I was… - A look back into our life I’ve talked a lot about Cing in my Another Code Recollection blog, about how this company really stuck with me and about my hope that somed...

5 months ago

Dear Me, I was... is so far my biggest surprise on
#NintendoSwitch2. It's a short textless adventure with gorgeous artwork and a story that is gonna leave with a lot of self reflection to do. Enjoy my blog!

#MarkusTavern #Blog #Review #Writing #Videogame #VisualNovel #Cing #ArcSystemWorks

8 3 2 7

Next-Gen ADHD Treatment: Cingulate Locks Exclusive Manufacturing Deal Through 2028 for CTx-1301 Biotech firm Cingulate secures exclusive US manufacturing partnership with Bend Bio Sciences for CTx-1301, its novel ADHD treatment, following July 2025 NDA submission. Deal runs through 2028.

5 months ago

#CINGW #CING Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment

www.stocktitan.net/news/CINGW/cingulate-sec...

0 0 0 0

Nintendo Hall

@nintendohall.bsky.social

6 months ago

Last Window: Il segreto di Cape West (NDS - The Secret of Cape West) Kyle Hyde - Game of the Sunday YouTube video by Nintendo Hall

Last Window: Il segreto di Cape West (NDS - The Secret of Cape West) Kyle Hyde - Game of the Sunday: www.youtube.com/watch?v=qb31... #LastWindow #hoteldusk #cing #nds #ds #nintendods #gameofthesunday #Retro #retrogames #Retrogaming #NintendoSwitch2 #Nintendotoday #domenica #sunday

1 1 0 0

Another Code Recollection - Un remake completamente inaspettato Vi è mai capitato di fare un salto in un negozio di videogiochi, scavare nello scatolone dei giochi usati e lanciarvi su un gioco che non av...

6 months ago

#Cing è una compagnia che ho scoperto completamente per caso e diventò in fretta una delle mie preferite. Quindi facciamo un salto di un anno e parliamo del loro quasi ritorno con #AnotherCodeRecollection per #NintendoSwitch

#Blog #Recensione #Videogame #PuzzleAdventure #VisualNovel #AnotherCode

3 2 0 0

Another Code Recollection - A completely unexpected remake Have you ever walked into the videogame store, mindlessly dug into the used game box and instinctively bought a game that you never heard of...

6 months ago

#Cing is a company I discovered entirely by chance and quickly became one of my favourites. So let's jump back a year and talk about their sort of return with #AnotherCodeRecollection on the #NintendoSwitch

#MarkusTavern #Blog #Review #Writing #Videogame #PuzzleAdventure #VisualNovel #AnotherCode

5 3 1 4

Zacks Small Cap Research

@zackssmallcap.bsky.social

6 months ago

#CING: NDA Submitted buff.ly/THrMY24

0 0 0 0

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25 Cingulate Inc. (NASDAQ: CING) received updated coverage from Stonegate Capital Partners following their Q2 2025 results. The company has made significant progress with its lead ADHD treatment CTx-1301, submitting its New Drug Application (NDA) to the FDA on July 31, 2025. The company expects FDA acceptance in Q4 2025 with a potential PDUFA date in mid-2026.The company's innovative Precision Timed Release (PTR) platform aims to improve ADHD treatment through true once-daily dosing. Financial position shows $8.9M in cash and $3.5M in working capital, sufficient to fund operations into late 2025. Phase 3 pediatric trial and fed/fast study demonstrated positive results, while commercialization preparations continue with Indegene for a planned mid-2026 launch.

6 months ago

#CING Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25

www.stocktitan.net/news/CING/stonegate-capi...

0 0 0 0

Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights Cingulate (NASDAQ: CING) has submitted a New Drug Application (NDA) to the FDA for CTx-1301, its lead ADHD treatment asset utilizing Precision Timed Release™ technology. The company expects an FDA decision on NDA acceptance in Q4 2025, with a potential PDUFA date in mid-2026.Key Q2 2025 financial results show cash position of $8.9 million, expected to last into late 2025. The company needs an additional $1.5 million for commercialization efforts. Q2 net loss widened to $4.8 million from $3.2 million year-over-year, with R&D expenses increasing 43.6% to $2.7 million. Cingulate secured a $25 million purchase agreement with Lincoln Park Capital over 36 months to support pre-commercial activities.

6 months ago

#CINGW #CING Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights

www.stocktitan.net/news/CINGW/cingulate-inc...

0 0 0 0

Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301 Cingulate Inc. (NASDAQ: CING) has submitted a New Drug Application (NDA) to the FDA for CTx-1301, its lead ADHD treatment candidate. The drug, utilizing Cingulate's proprietary Precision Timed Release™ (PTR™) platform, is designed to provide once-daily dosing with fast onset and entire active-day efficacy.CTx-1301 is a novel extended-release formulation of dexmethylphenidate HCl that aims to address major limitations of current ADHD therapies. The company expects to receive notification of NDA acceptance within 60 days of its July 31 submission. The drug targets the $23 billion U.S. ADHD market and represents the first regulatory application of Cingulate's PTR™ platform technology.

7 months ago

#CINGW #CING Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

www.stocktitan.net/news/CINGW/cingulate-sub...

0 0 0 0